Living Homeopathy International LTD F-1 registration statements
The S-1’s counterpart for foreign private issuers registering shares for sale in the United States.
NASDAQ
Living Homeopathy International Ltd., a leading Hong Kong-based homeopathy provider, filed for an initial public offering on the Nasdaq Capital Market, reporting a significant increase in net income for the six months ended September 30, 2025.
NASDAQ
Living Homeopathy International Ltd., a Hong Kong-based homeopathy service provider, filed an amendment for its initial public offering of 1,250,000 Class A Ordinary Shares on the Nasdaq Capital Market, with an estimated price range of $4.0 to $6.0 per share.
NASDAQ
Living Homeopathy International Ltd., a leading Hong Kong homeopathy service provider, is pursuing a Nasdaq Capital Market IPO of 1.25 million Class A ordinary shares.
NASDAQ
Living Homeopathy International Ltd. files an amended F-1 registration statement for its proposed Nasdaq Capital Market IPO of 1,250,000 Class A Ordinary Shares, highlighting its leading market share in Hong Kong's homeopathy sector amidst regulatory uncertainties.
NASDAQ
Living Homeopathy International Ltd., a Hong Kong-based homeopathy service provider, has filed an F-1 registration statement for an initial public offering of 1,250,000 Class A ordinary shares on the Nasdaq Capital Market, seeking to raise approximately $4.13 million in net proceeds despite recent declines in revenue and a shift to net loss in the most recent interim period.